Active Ingredient(s):Imiglucerase FDA Approved: * May 23, 1994 Pharm Company: *GENZYME Category:Enzymes
Imiglucerase is a medication used in the treatment of Gaucher's disease.
It is a recombinant DNA-produced analogue of the human enzyme β-glucocerebrosidase.
Cerezyme is a freeze-dried medicine containing imiglucerase, manufactured by Genzyme Corporation. It is given intravenously after reconstitution as a treatment for Type 1 and Type 3 Gaucher's disease. It is available in formulations containing 200 or 400 units per vial. The sp...
* May have multiple approval dates, manufacturers, or labelers.
Cerezyme 40 U/Ml Intravenous Injection, Powder, Lyophilized, for Solution